SCHOTT Introduces Prefillable Polymer Syringe for Infusion Therapy Devices - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

SCHOTT Introduces Prefillable Polymer Syringe for Infusion Therapy Devices

Equipment and Processing Report

SCHOTT expanded its range of TopPac prefillable polymer syringes (PFS) to include a 20-mL format that can be used in combination with syringe pumps in infusion therapy. Prefillable syringes significantly reduce the risk of medication errors compared to manual transfer of a drug from a primary container to a disposable syringe. This accuracy is crucial for infusion therapy, in which common medications (e.g., pain medications, anesthetics, and cardiovascular medications) have a narrow safety margin. TopPac PFS are compatible with various syringe pumps, and the exact outer diameter enables automated recognition by the syringe pumps. The syringes are also compatible with intravenous devices (e.g., needleless luer access devices). TopPac PFS’ optimized siliconization ensures consistent gliding forces for smooth drug application and also reduces the interaction of silicone with the drug throughout its shelf life.

Source: Schott

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
31%
Breakthrough designations
8%
Protecting the supply chain
42%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Equipment and Processing Report,
Click here